- Amended Current report filing (8-K/A)
December 19 2011 - 4:37PM
Edgar (US Regulatory)
UNITED STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest event Reported): June 20,
2011
CHINA BIOLOGIC PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
001-34566
|
75-2308816
|
(State or other jurisdiction of
|
(Commission File No.)
|
(IRS Employer ID No.)
|
incorporation or organization)
|
|
|
No. 14 East Hushan Road,
|
Tai'an City, Shandong, 271000
|
People's Republic of China
|
(Address of Principal Executive Offices)
|
86-538 -620-2306
|
Registrant's telephone number, including area code
|
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (
see
General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e -4(c))
Explanatory Note
This current report on Form 8-K/A (the Amendment) updates
information provided on a current report on Form 8-K dated June 23, 2011 (the
Original Form 8-K), relating to disclosure made under Item 5.07, Submission of
Matters to a Vote of Security Holders, associated with the China Biologic
Products, Inc. (the Company) Annual Meeting of Stockholders held on June 20,
2011 (the Annual Meeting). The sole purpose of this Amendment is to disclose
the Companys decision regarding how frequently it will conduct an advisory vote
on the compensation of the Companys named executive officers.
Item 5.07 Submission of Matters to a Vote of Security
Holders.
As previously reported in the Original Form 8-K, on June 23,
2011, at the Companys Annual Meeting pursuant to notice duly given, the Company
held a non-binding advisory vote of stockholders on the preferred frequency with
which the Company would hold a non-binding advisory stockholder vote to approve
the compensation of the named executive officers, as disclosed in the Companys
proxy statements. The results of the voting for this proposal were as follows:
Every year
|
Every two years
|
Every three years
|
Abstain
|
11,062,944
|
3,665
|
36,548
|
4,598,941
|
The Company has considered the outcome of this advisory vote
and has determined that the Company will hold an annual advisory vote on the
compensation of the Companys named executive officers.
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 19, 2011
|
CHINA BIOLOGIC PRODUCTS, INC.
|
|
|
|
|
|
By:
/s/ Chao Ming Zhao
|
|
Chao Ming Zhao
|
|
Chief Executive Officer
|
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024